AMANDA LYNN: Open Payments
NPI 1578956371 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,425 in 106 payments from 24 companies in 2025. Trend: 2023 $1,041 · 2024 $1,741 · 2025 $2,425
Food & beverage: $2,425
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $452 |
| Axsome Therapeutics, Inc. | 2 | $262 |
| Amgen Inc. | 18 | $259 |
| ABBVIE INC. | 15 | $246 |
| Lilly USA, LLC | 16 | $209 |
| Medtronic, Inc. | 3 | $157 |
| Sumitomo Pharma America, Inc. | 5 | $124 |
| SANOFI-AVENTIS U.S. LLC | 1 | $122 |
| Novartis Pharmaceuticals Corporation | 6 | $106 |
| Phathom Pharmaceuticals, Inc. | 9 | $64 |
Products named: Auvelity, REPATHA, QULIPTA, MOUNJARO, COBALT DR MRI SURESCAN, AIRSUPRA, GEMTESA, TZIELD.
Industry payments across NE — which companies pay providers there.
